Patents by Inventor Lev KHMELNITSKY

Lev KHMELNITSKY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMANIZED ANTI QUIESCIN SUEFHYDRYE OXIDASE 1 (QSOX1) ANTIBODIES AND USES THEREOF
    Publication number: 20250092158
    Abstract: The present invention provides humanized monoclonal antibodies that specifically recognize human QSOX1 and inhibit its activity. The humanized antibodies of the present invention were designed following in-silico selection of specific variable region segments, based on their energy scores, and were produced and confirmed to function properly in binding and inhibiting human QSOX1. The present invention further provides pharmaceutical compositions comprising the humanized antibodies and methods for their use in cancer therapy and diagnosis.
    Type: Application
    Filed: August 4, 2022
    Publication date: March 20, 2025
    Applicant: YEDA RESEARCH AND DEVELOPMENT CO. LTD.
    Inventors: Deborah FASS, Sarel FLEISHMAN, Lev KHMELNITSKY, Ariel TENNENHOUSE
  • CHIMERIC QUIESCIN SULFHYDRYL OXIDASE (QSOX1) ANTIBODIES AND USES OF SAME
    Publication number: 20210292437
    Abstract: Antibodies for binding QSOX1 are provided. Also provided are use of these antibodies.
    Type: Application
    Filed: August 14, 2019
    Publication date: September 23, 2021
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: Deborah FASS, Sarel FLEISHMAN, Shira WARSZAWSKI, Iris GROSSMAN, Lev KHMELNITSKY